Structural motifs of importance for the constitutive activity of the orphan 7TM receptor EBI2: Analysis of receptor activation in the absence of an agonist

被引:29
作者
Benned-Jensen, Tau [1 ]
Rosenkilde, Mette M. [1 ]
机构
[1] Univ Copenhagen, Panum Inst, Mol Pharmacol Lab, Dept Neurosci & Pharmacol,Fac Hlth Sci, DK-2200 Copenhagen, Denmark
基金
英国医学研究理事会;
关键词
D O I
10.1124/mol.108.049676
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The Epstein-Barr induced receptor 2 (EBI2) is a lymphocyte-expressed orphan seven transmembrane-spanning (7TM) receptor that signals constitutively through G alpha(i), as shown, for instance by guanosine 5 '-O-(3-thio)triphosphate incorporation. Two regions of importance for the constitutive activity were identified by a systematic mutational analysis of 29 residues in EBI2. The cAMP response element-binding protein transcription factor was used as a measure of receptor activity and was correlated to the receptor surface expression. PheVI:13 (Phe(257)), and the neighboring CysVI:12 (Cys(256)), in the conserved CW/FxP motif in TM 6, acted as negative regulators as Ala substitutions at these positions increased the constitutive activity 5.7- and 2.3-fold, respectively, compared with EBI2 wild type (wt). In contrast, ArgII:20 (Arg(87)) in TM-2 acted as a positive regulator, as substitution to Ala, but not to Lys, decreased the constitutive activity more than 7-fold compared with wt EBI2. IleIII:03 (Ile106) is located only 4 angstrom from ArgII: 20, and a favorable electrostatic interaction with ArgII: 20 was created by introduction of Glu in III:03, given that the activity increased to 4.4-fold of that wt EBI2. It is noteworthy that swapping these charges by introduction of Glu in II:20 and Arg in III:03 resulted in a 2.7-fold increase compared with wt EBI2, thereby rescuing the two signaling-deficient single mutations, which exhibited a 3.8- to 4.5-fold decrease in constitutive activity. The uncovering of these molecular mechanisms for EBI2 activation is important from a drug development point of view, in that it may facilitate the rational design and development of small-molecule inverse agonists against EBI2 of putative importance as antiviral- or immune modulatory therapy.
引用
收藏
页码:1008 / 1021
页数:14
相关论文
共 41 条
[1]   Constitutive activation of CCR5 and CCR2 induced by conformational changes in the conserved TXP motif in transmembrane helix 2 [J].
Arias, DA ;
Navenot, JM ;
Zhang, WB ;
Broach, J ;
Peiper, SC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (38) :36513-36521
[2]   G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator [J].
Bais, C ;
Santomasso, B ;
Coso, O ;
Arvanitakis, L ;
Raaka, EG ;
Gutkind, JS ;
Asch, AS ;
Cesarman, E ;
Gerhengorn, MC ;
Mesri, EA .
NATURE, 1998, 391 (6662) :86-89
[3]   THE PROBABLE ARRANGEMENT OF THE HELICES IN G-PROTEIN-COUPLED RECEPTORS [J].
BALDWIN, JM .
EMBO JOURNAL, 1993, 12 (04) :1693-1703
[4]  
Ballasteros J. A., 1995, Methods in neurosciences, V25, P366
[5]   The Epstein-Barr virus BILF1 gene encodes a G protein-coupled receptor that inhibits phosphorylation of RNA-dependent protein kinase [J].
Beisser, PS ;
Verzijl, D ;
Gruijthuijsen, YK ;
Beuken, E ;
Smit, MJ ;
Leurs, R ;
Bruggeman, CA ;
Vink, C .
JOURNAL OF VIROLOGY, 2005, 79 (01) :441-449
[6]   EPSTEIN-BARR VIRUS-INDUCED GENES - 1ST LYMPHOCYTE-SPECIFIC G-PROTEIN-COUPLED PEPTIDE RECEPTORS [J].
BIRKENBACH, M ;
JOSEFSEN, K ;
YALAMANCHILI, R ;
LENOIR, G ;
KIEFF, E .
JOURNAL OF VIROLOGY, 1993, 67 (04) :2209-2220
[7]   High-resolution crystal structure of an engineered human β2-adrenergic G protein-coupled receptor [J].
Cherezov, Vadim ;
Rosenbaum, Daniel M. ;
Hanson, Michael A. ;
Rasmussen, Soren G. F. ;
Thian, Foon Sun ;
Kobilka, Tong Sun ;
Choi, Hee-Jung ;
Kuhn, Peter ;
Weis, William I. ;
Kobilka, Brian K. ;
Stevens, Raymond C. .
SCIENCE, 2007, 318 (5854) :1258-1265
[8]   Metal ion site engineering indicates a global toggle switch model for seven-transmembrane receptor activation [J].
Elling, Christian E. ;
Frimurer, Thomas M. ;
Gerlach, Lars-Ole ;
Jorgensen, Rasmus ;
Holst, Birgitte ;
Schwartz, Thue W. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (25) :17337-17346
[9]   Requirement of rigid-body motion of transmembrane helices for light activation of rhodopsin [J].
Farrens, DL ;
Altenbach, C ;
Yang, K ;
Hubbell, WL ;
Khorana, HG .
SCIENCE, 1996, 274 (5288) :768-770
[10]   Activation of CCR5 by chemokines involves an aromatic cluster between transmembrane helices 2 and 3 [J].
Govaerts, C ;
Bondue, A ;
Springael, JY ;
Olivella, M ;
Deupi, X ;
Le Poul, E ;
Wodak, SJ ;
Parmentier, M ;
Pardo, L ;
Blanpain, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (03) :1892-1903